14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ELDN stock ended at $2.41. This is 4.78% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 10.89% from a day low at $2.28 to a day high of $2.53.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Eledon Pharmaceuticals, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $2.38 $2.53 $2.28 $2.41 177 983
May 02, 2024 $2.38 $2.39 $2.24 $2.30 118 496
May 01, 2024 $2.43 $2.43 $2.13 $2.29 146 819
Apr 30, 2024 $2.38 $2.40 $2.29 $2.39 91 966
Apr 29, 2024 $2.07 $2.43 $2.05 $2.37 316 889
Apr 26, 2024 $2.05 $2.08 $2.00 $2.06 81 544
Apr 25, 2024 $1.97 $2.09 $1.91 $2.02 67 362
Apr 24, 2024 $2.18 $2.20 $1.96 $1.97 100 464
Apr 23, 2024 $2.01 $2.20 $2.00 $2.16 190 022
Apr 22, 2024 $2.00 $2.20 $1.92 $2.02 312 621
Apr 19, 2024 $2.11 $2.18 $1.78 $1.86 420 099
Apr 18, 2024 $1.55 $2.00 $1.55 $1.99 306 044
Apr 17, 2024 $1.58 $1.68 $1.56 $1.57 12 446
Apr 16, 2024 $1.64 $1.67 $1.56 $1.60 16 773
Apr 15, 2024 $1.64 $1.67 $1.54 $1.64 69 540
Apr 12, 2024 $1.65 $1.73 $1.56 $1.69 32 283
Apr 11, 2024 $1.70 $1.76 $1.62 $1.66 43 021
Apr 10, 2024 $1.66 $1.73 $1.66 $1.68 45 293
Apr 09, 2024 $1.74 $1.77 $1.54 $1.66 49 226
Apr 08, 2024 $1.72 $1.74 $1.68 $1.73 21 648
Apr 05, 2024 $1.76 $1.78 $1.66 $1.72 198 038
Apr 04, 2024 $1.73 $1.80 $1.72 $1.76 98 955
Apr 03, 2024 $1.92 $1.92 $1.67 $1.69 169 854
Apr 02, 2024 $2.00 $2.00 $1.85 $1.93 65 208
Apr 01, 2024 $2.10 $2.10 $1.90 $1.99 107 541
Click to get the best stock tips daily for free!

About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals. Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical tri... ELDN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT